IUCD Complication
Conditions
Brief summary
our aims to investigate the effectiveness of10% Lidocaine Spray plus oral celecoxib for Pain Control During Hysterosalpingography
Detailed description
hysterosalpingography can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring uterine depth, inserting the cannula; and injection of the dye
Interventions
DRUGcelecoxib plus lidocaine
Celecoxib 200 mg (Celebrex® 200, Pfizer,USA) administered orally 2 h before the procedure +10% lidocaine spray 4 puffs during the procedure
DRUGCelecoxib
Celecoxib 200 mg (Celebrex® 200, Pfizer,USA) administered orally 2 h before the procedure +Sterile water 4 puffs during the procedure
DRUGlidocaine
placebo to celecoxib administered orally 2 h before the procedure +10% lidocaine spray 4 puffs during the procedure
Sponsors
Aswan University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)
Masking description
randomized controlled trial
Intervention model description
randomized controlled trial
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
* any patient came for Hysterosalpingography
Exclusion criteria
* any patient has contraindication to Hysterosalpingography
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mean pain score during the procedure | 10 minuets | Assessment of pain using visual analog scale 0-10, 0 = minimum and 10 = maximum scores |
Countries
Egypt
Outcome results
None listed